Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shady Grove Fertility has over three decades of experience providing evidence-based fertility care. As of September 2021, the practice reported more than 100,000 babies born through its services. It operates one of the highest-volume embryology labs in the U.S. and offers individualized treatment plans including IVF, IUI, donor egg/sperm programs, gestational carrier services, and advanced genetic testing. The group collaborates with academic institutions on research and training programs.[5][1][3] Clinical outcomes are among the best nationally; SGF’s labs account for nearly five percent of all ART cycles performed annually in the U.S.[1] The company emphasizes patient-centered care with high satisfaction rates (>96% would recommend), broad insurance acceptance/financial options,[3] and ongoing expansion across multiple states.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shady Grove Fertility.